Plus Therapeutics Partners with GTC to Expand CNSide Platform
HOUSTON & LAKE FOREST, Calif., July 16, 2026 Plus Therapeutics and Genomic Testing Cooperative (GTC) announced a strategic collaboration...
NCCN Guidelines
Advertisement
Plus Therapeutics Reinforces CNSide Clinical Value Following NCCN Guideline Update
HOUSTON, July 14, 2026 Plus Therapeutics highlighted updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for...
Partner Therapeutics Files sBLA for BIZENGRI in CCA
LEXINGTON, MASSACHUSETTS, USA, April 14, 2026 Partner Therapeutics, Inc. has announced the submission of a supplemental Biologics License Application...
Delcath CHEMOSAT Gains ESMO Guideline Recognition Boost
Queensbury, New York, USA, April 6, 2026 ESMO Guideline Inclusion Validates CHEMOSAT Therapy In a major milestone for interventional...
FDA Approves Jazz Pharma’s Zepzelca + Tecentriq Combo for ES-SCLC
DUBLIN, Oct. 2, 2025 – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the U.S. Food and Drug Administration...
Advertisement
